Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

97.50
+0.81000.84%
Post-market: 97.510.0100+0.01%19:59 EDT
Volume:8.71M
Turnover:845.01M
Market Cap:169.54B
PE:31.55
High:97.59
Open:97.25
Low:95.06
Close:96.69
52wk High:135.37
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.11
T/O Rate:0.51%
Dividend:2.48
Dividend Rate:2.54%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.32
PE(LYR):26.14

Loading ...

Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)

TIPRANKS
·
Aug 28

Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares

Reuters
·
Aug 28

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Abbott Laboratories' Stroke Treatment Device Receives CE Mark

MT Newswires Live
·
Aug 27

Abbott - to Expand Amulet 360 Use Across Europe in Coming Weeks

THOMSON REUTERS
·
Aug 27

Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark

THOMSON REUTERS
·
Aug 27

Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke

THOMSON REUTERS
·
Aug 27

Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe

Reuters
·
Aug 27

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26

Piper Sandler Sticks to Their Buy Rating for Abbott Laboratories (ABT)

TIPRANKS
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Aug 26

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
Aug 26

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Aug 26

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Aug 26

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Aug 26

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Aug 26

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Aug 26